Creative Planning’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$252K Buy
60,322
+40,281
+201% +$194K ﹤0.01% 3557
2025
Q4
$96.4K Buy
+20,041
New +$96.9K ﹤0.01% 3720
2023
Q4
Sell
-10,936
Closed -$28.3K 2786
2023
Q3
$28.3K Sell
10,936
-100
-0.9% -$351 ﹤0.01% 2552
2023
Q2
$43.5K Sell
11,036
-5,764
-34% -$18.3K ﹤0.01% 2450
2023
Q1
$56.8K Sell
16,800
-905
-5% -$3.69K ﹤0.01% 2333
2022
Q4
$63.4K Sell
17,705
-515
-3% -$2.2K ﹤0.01% 2201
2022
Q3
$73K Hold
18,220
﹤0.01% 2078
2022
Q2
$81K Buy
+18,220
New +$131K ﹤0.01% 1996
2021
Q2
Sell
-11,025
Closed -$113K 2124
2021
Q1
$113K Buy
+11,025
New +$153K ﹤0.01% 2227

Other funds holding SRTA

Creative Planning's SRTA Position: Q1 2026 in Review

Creative Planning increased its Strata Critical Medical Inc (SRTA) stake by 201% in Q1 2026, buying an estimated $194K and bringing the position to 60,322 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #3557.

Creative Planning first reported a position in SRTA in Q1 2021 and has held it in 9 quarters since. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Creative Planning held 60,322 shares of Strata Critical Medical Inc worth $252K as of Q1 2026.
  • Creative Planning bought 40,281 Strata Critical Medical Inc shares in Q1 2026, an estimated $194K.
  • Strata Critical Medical Inc made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #3557 holding.
  • Creative Planning first reported a position in Strata Critical Medical Inc in Q1 2021 and has held it in 9 quarters since.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.